Similar data were obtained in the work of Arthur et al. for ductal carcinoma in situ: the level of SHBG had inverse correlations with the risk of disease in postmenopausal women (HR = 0.75) and was not associated with the disorder in premenopausal women [44]. Here, SHBG is linked to ductal breast carcinoma in situ.